However, you should always inform healthcare providers about all medications you're taking for comprehensive medical care
Beginning as early as April 1, 2026, Medicare beneficiaries will pay no more than $50 per month for Lillys Zepbound (tirzepatide), available in a multi-dose pen, and for orforglipron, Lilly's once-daily obesity pill, provided both receive approval from the US Food and Drug Administration (FDA), according to a news release from Lilly
If you want to improve your digestive health, fiber-rich cabbage is a great option
The launch marks the dairy giants latest push to position its Oikos brand at the center of functional nutrition
Center S, Harte J, Watrous D, et al
Adaptive Capacity Enhancement: Supporting the body's ability to adapt to various stressors, promoting resilience at a cellular level